ResultsIQ

ResultsIQ › Latest results › India Pesticides Limited

India Pesticides Limited Q3 FY26 results deck summary

NSE: IPL · BSE: 543311

Results deck of 10 Feb 2026, summarised by AI from the filing.

Q3 FY26 total income ₹229 cr (+30.7% YoY), EBITDA ₹41 cr (+39.7% YoY), PAT ₹23 cr (+41.2% YoY); capex of ₹116 cr planned for FY26.

Key takeaways

  1. Q3 FY26 results Total income ₹229 cr (Q3 FY25: ₹175 cr, +30.7% YoY); EBITDA ₹41 cr (+39.7% YoY); PAT ₹23 cr (+41.2% YoY).
  2. Capex guidance Planned capital expenditure of ₹116 cr for FY26 to boost capacity.
  3. Volume growth Overall volume growth of approximately 32% in Q3 FY26, supported by improved capacity utilization.
  4. Export demand Export sales increased to ₹96 cr from ₹75 cr in Q3 FY25, led by European Union and Australia.
  5. Price softening Realizations were slightly lower due to price softening in certain molecules.

Original filing on BSE

India Pesticides Limited Q1 FY27 results

As filed: Revenue ₹252 cr (−8% year on year), EBITDA ₹35.5 cr (−21% year on year), PAT ₹22.8 cr (−35% year on year), EBITDA margin 14.1% (−227 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹266 cr (+29% year on year), EBITDA ₹41.8 cr (+31% year on year), PAT ₹30.6 cr (+39% year on year), EBITDA margin 15.7% (+24 bps). Score 75 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 24 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +2.8% in 30 days (Nifty 500: +2.7%).
  • Q3 FY26: Revenue ₹225 cr (+31% year on year), EBITDA ₹37.7 cr (+45% year on year), PAT ₹22.7 cr (+42% year on year), EBITDA margin 16.7% (+161 bps). Score 65 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 161 bps year on year. Revenue rose ₹53.4 cr on a year ago, more than the ₹21.0 cr it added the year before. Share price after the results: −16.2% in 30 days (Nifty 500: −6.9%).
  • H1 FY26: Revenue ₹565 cr, EBITDA ₹94.0 cr, PAT ₹67.0 cr, EBITDA margin 16.6%. Not scored. No result for the same half-year last year. Share price after the results: −12.1% in 30 days (Nifty 500: −0.6%).
  • Q1 FY26: Revenue ₹275 cr (+25% year on year), EBITDA ₹45.0 cr (+61% year on year), PAT ₹35.0 cr (+84% year on year), EBITDA margin 16.4% (+364 bps). Score 76 of 100, Above trend. Revenue and profit growth were above the company's own trend; EBITDA growth was in line with it. EBITDA margin rose 364 bps year on year. Profit rose ₹16.0 cr on a year ago, more than the ₹4.0 cr it added the year before. Share price after the results: −7.4% in 29 days (Nifty 500: +0.6%).
  • Q4 FY25: Revenue ₹207 cr (+64% year on year), EBITDA ₹32.0 cr (+300% year on year), PAT ₹22.0 cr (+300% year on year), EBITDA margin 15.5% (+1,000 bps). Score 100 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 1000 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +29.7% in 30 days (Nifty 500: +1.7%).
  • Q3 FY25: Revenue ₹172 cr (+14% year on year), EBITDA ₹26.0 cr (−21% year on year), PAT ₹16.0 cr (−33% year on year), EBITDA margin 15.1% (−674 bps). Score 46 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 674 bps year on year. Revenue fell 25% from last quarter.
  • Q2 FY25: Revenue ₹229 cr (+13% year on year), EBITDA ₹34.0 cr (+21% year on year), PAT ₹26.0 cr (+30% year on year), EBITDA margin 14.9% (+99 bps). Score 65 of 100, In line with trend. EBITDA margin rose 99 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

India Pesticides Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.